These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G. Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [Abstract] [Full Text] [Related]
3. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M. Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978 [Abstract] [Full Text] [Related]
7. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. Levine PH, Connelly RR, Herberman RB, McCoy JL, Fabrizio PL. IARC Sci Publ (1971); 1975 Aug 15; (11 Pt 2):225-35. PubMed ID: 191366 [Abstract] [Full Text] [Related]
8. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease. Stepina VN, Gourtsevicz VE, Mazurenko NP, Yarymova NM, Kaverznyeva MM, Lorye YI. Neoplasma; 1976 Aug 15; 23(5):523-32. PubMed ID: 185535 [Abstract] [Full Text] [Related]
9. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N. Srp Arh Celok Lek; 1998 Aug 15; 126(3-4):97-100. PubMed ID: 9863363 [Abstract] [Full Text] [Related]
10. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease. Mochanko K, Fejes M, Breazavscek DM, Suarez A, Bachmann AE. Cancer; 1979 Dec 15; 44(6):2065-70. PubMed ID: 228834 [Abstract] [Full Text] [Related]
13. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease. Levine PH, Reisher JI. Natl Cancer Inst Monogr; 1973 May 15; 36():85-7. PubMed ID: 4355354 [No Abstract] [Full Text] [Related]
14. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Jumbou O, Mollat C, N'Guyen JM, Billaudel S, Litoux P, Dréno B. Br J Dermatol; 1997 Feb 15; 136(2):212-6. PubMed ID: 9068734 [Abstract] [Full Text] [Related]
15. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease. Rocchi G, Tosato G, Papa G, Ragona G. Int J Cancer; 1975 Aug 15; 16(2):323-8. PubMed ID: 168161 [Abstract] [Full Text] [Related]
16. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. ten Napel CH, van Egten-Bijker J, Halie MR, Langenhuysen MM, The TH. J Clin Lab Immunol; 1980 Nov 15; 4(3):145-51. PubMed ID: 6259357 [Abstract] [Full Text] [Related]
19. A case control study on immunity to two Epstein-Barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with Hodgkin's disease in Denmark, 1971-73. Hesse J, Levine PH, Ebbesen P, Connelly RR, Mordhorst CH. Int J Cancer; 1977 Jan 15; 19(1):49-58. PubMed ID: 188770 [Abstract] [Full Text] [Related]